
    
      The purpose of this clinical investigation is to establish the safety and efficacy of the
      ComprehensiveÂ® Shoulder System with Nano Humeral Component in Total Shoulder Arthroplasty.
      Safety and efficacy of the device will be measured by collection and analysis of the
      following data at the two-year or greater time point (22 months post-operative or longer):

        1. American Shoulder and Elbow Surgeons (ASES) Score

        2. Single Assessment Numeric Evaluation (SANE)

        3. Constant Score

        4. Radiographic assessment of osteolysis, radiolucencies, migration, and subsidence

        5. Comparison of overall adverse event rates including rates of removal/revision and other
           serious adverse events.
    
  